Werkgroep Cardiologische centra Nederland

Ivabradine MR CAD (Completed)

Study: CL3-16257-097, a randomised, double-blind, parallel groups, multicentre trial. Safety of oral chronic administration of ivabradine MRcompared to ivabradine immediate release formulation, in patients with stable coronary artery disease.
Medicine
Ivabradine MR
Population
ASCVD
Phase
III
Starting year
2012
More information
ClinicalTrialsRegister.eu

Director of Study

dr. J.A. Kragten (Cardioloog)
Heerlen, Zuyderland Medisch Centrum